Urine biomonitoring of occupational exposure to methotrexate using a highly sensitive UHPLC-MS/MS method in MRM3 mode

Comparison of LC–MS3 and LC–MRM strategy for quantification of methotrexate in human plasma and its application in therapeutic drug monitoring

(2021) Lei Yin et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Quantification of healthcare workers’ exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study

(2020) Marie Palamini et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Molecular mechanism of action and pharmacokinetic properties of methotrexate

(2020) V. Maksimovic et al.   MOLECULAR BIOLOGY REPORTS

A highly sensitive UHPLC-MS/MS method for urine biological monitoring of occupational exposure to anthracycline antineoplastic drugs and routine application

(2020) Antoine Villa et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Safety of drugs used for the treatment of Crohn’s disease

(2019) Aviv Pudipeddi et al.   Expert Opinion On Drug Safety

Application of an innovative high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous analysis of 18 hazardous drugs to rule out accidental acute chemotherapy exposures in health care workers

(2019) Pan Shu et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Biomonitoring of occupational exposure to 5-fluorouracil by assaying α-fluoro-β-alanine in urine with a highly sensitive UHPLC-MS/MS method

(2018) Alice Dhersin et al.   ANALYST

A UHPLC–MS/MS-based method for the simultaneous monitoring of eight antiblastic drugs in plasma and urine of exposed healthcare workers

(2018) Viviana Izzo et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2017) Richard B Warren et al.   LANCET

Should methotrexate remain the first-line drug for psoriasis?

(2017) Dafna D Gladman   LANCET

Dispersive solid-phase extraction procedure coupled to UPLC-ESI-MS/MS analysis for the simultaneous determination of thirteen cytotoxic drugs in human urine

(2016) Giovanni Fabrizi et al.   BIOMEDICAL CHROMATOGRAPHY

Highly sensitive LC–MS/MS methods for urinary biological monitoring of occupational exposure to cyclophosphamide, ifosfamide, and methotrexate antineoplastic drugs and routine application

(2016) Mireille Canal-Raffin et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers

(2016) Céline Poupeau et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Optimizing methotrexate therapy in rheumatoid arthritis: A systematic literature review

(2011) Gaël Mouterde et al.   JOINT BONE SPINE

Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature

(2008) K Visser et al.   ANNALS OF THE RHEUMATIC DISEASES